RDHL
Redhill Biopharma Ltd.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
Actual EPS |
---|
Consensus EPS |
Estimated EPS |
Number of Estimates |
EPS Surprise |
Stats
Summary
redhill biopharma is a biopharmaceutical company focused primarily on development of late clinical-stage new, improved and patented formulations of existing drugs. redhill has an experienced management team, board of directors and advisory board based in israel, the us, canada and europe, with successful track record at big and small pharma of bringing patented drugs to the market, as well as extensive managerial, financial, and transactional expertise
Market Cap: 497 Thousand
Primary Exchange: NASDAQ
Website: https://www.redhillbio.com/
Shares Outstanding: 882 Thousand
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.24453398747323601
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 1758 trading days
From: 2015-06-16 To: 2024-03-07
Lowest Point:
RedHill nabs U.S. patent covering RHB-104 and RHB-204
via: SeekingAlpha at 2019-06-10 11:21:52:000
The USPTO has issued a Notice of Allowance to RedHill Biopharma ( RDHL -0.8% ) for a new patent covering RHB-104 for Crohn's disease and RHB-204 for Mycobacterium avium complex disease. Once issued, the patent should be effective until at least 2029. More news on: RedHill B… read more...
RedHill nabs U.S. patent covering RHB-104 and RHB-204
via: SeekingAlpha at 2019-06-10 11:21:52:000
The USPTO has issued a Notice of Allowance to RedHill Biopharma ( RDHL -0.8% ) for a new patent covering RHB-104 for Crohn's disease and RHB-204 for Mycobacterium avium complex disease. Once issued, the patent should be effective until at least 2029. More news on: RedHill B… read more...
RedHill nabs U.S. patent covering RHB-104 and RHB-204
via: SeekingAlpha at 2019-06-10 11:21:52:000
The USPTO has issued a Notice of Allowance to RedHill Biopharma ( RDHL -0.8% ) for a new patent covering RHB-104 for Crohn's disease and RHB-204 for Mycobacterium avium complex disease. Once issued, the patent should be effective until at least 2029. More news on: RedHill B… read more...
Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
---|
Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
---|